FCRL4 and autoimmune disease: FcRH4- CD27- switch memory B cells may be more responsive to activation and may expand more easily in autoimmune diseases than their CD27-, FcRH4+ counterparts, because FcRH4 is a potent inhibitor of B-cell signaling [25].